FINANCIAL DISCLOSURE
Jerry Meece has received honoraria from Bayer, Eli Lilly, LifeScan, Novartis, Novo Nordisk Inc., and Sanofi-Aventis. He has been a consultant for Eli Lilly, LifeScan, Novartis, and Novo Nordisk Inc. He has also served on the speakers' bureaus for Bayer, Eli Lilly, LifeScan, Novo Nordisk Inc., and Sanofi-Aventis.

ACCREDITATION STATEMENTS
Pharmacists

Jobson is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Program No.: 430-000-06-027-H01
Credits: 2.0 hours (.20 ceu)

Nursing Continuing Education
This program has been approved by the The Nurse Practitioner Association New York State (the NPA) for 2.4 contact hours.

Estimated time to complete activity:
Estimated time to complete this monograph and posttest is 90 to 120 minutes.

Exam processing inquiries and booklet orders to:
CE Customer Service Manager (800) 825-4696

Direct educational content inquiries to:
CE Director (800) 331-9396

TARGET AUDIENCE
This accredited program is targeted to pharmacists, paharmacy technicians and nurse practitioners.

PROCEDURES
To receive credit and your exam score, please complete the exam questions and program evaluation.

GOAL
The goal of this program is to provide clinicians with current clinical data on more targeted approaches to improving glycemic control in patients with diabetes.

EDUCATIONAL OBJECTIVES
At the conclusion of this program, participants will be able to:

1. State the prevalence of diabetes and the increased risk of complications and mortality in patients under poor glycemic control;

2. Describe the relationship between glycemic control and blood glucose variability, including the benefits of optimal blood glucose management;

3. Discuss the importance of preventing and controlling postprandial blood glucose excursions;

4. Discuss self-monitoring of blood glucose (SMBG) and its relationship to glycosylated hemoglobin (A1c) values; and

5. Explain the value of empowering patients to achieve glycemic goals by overcoming barriers to SMBG and helping patients to understand their blood glucose values.

Disclosure of Unlabeled Use and Disclaimer
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Power-Pak C.E. and LifeScan, Inc.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

The author, sponsor, and publisher of this continuing education program have made all reasonable efforts to ensure that all information contained herein is accurate in accordance with the latest available scientific knowledge at the time of acceptance for publication. However, because information regarding drugs (their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions, etc.) is subject to constant change, the reader is advised to check the manufacturer's package insert for information concerning recommended dosages and potential problems and cautions prior to dispensing or administering the drug. Special precautions should be taken when a drug is new, or highly toxic, or is unfamiliar to the dispenser or administrant. This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the US Food and Drug Administration (FDA). Neither the publisher nor sponsor promotes the use of any agent outside of approved labeling. Statements made in this monograph have not been evaluated by the FDA. Nutritional products discussed are not intended for the diagnosis, treatment, cure, or prevention of any disease.